SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
HONG KONG, Dec. 17, 2025 /PRNewswire/ -- Recently, Meizhou in Guangdong, known as the "World Capital of the Hakka", welcomed a globally watched event, the...
SHANGHAI, Dec. 17, 2025 /PRNewswire/ -- Global investment in computing infrastructure is accelerating, driving technology upgrades and service innovation across the artificial intelligence industry...
From 115-inch cinematic displays to 55-inch premium formats, the new lineup offers enhanced color precision and intelligent processing capabilities SEOUL, South Korea, Dec....